Columbia Wanger Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Columbia Wanger Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$54.8M	Buy	1,601,233 +446,897	+39%	+$14.2M	0.82%	31
2017 Q3	$37M	Sell	1,154,336 -281,059	-20%	-$8.86M	0.55%	74
2017 Q2	$46.7M	Sell	1,435,395 -172,254	-11%	-$5.46M	0.67%	54
2017 Q1	$50.6M	Buy	1,607,649 +332,311	+26%	+$9.83M	0.71%	40
2016 Q4	$37.5M	Buy	1,275,338 +806,782	+172%	+$24.6M	0.53%	79
2016 Q3	$13.6M	Buy	+468,556	New	+$13.1M	0.18%	167

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Columbia Wanger Asset Management's GHDX Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Genomic Health, Inc. (GHDX) stake by 39% in Q4 2017, buying an estimated $14.2M and bringing the position to 1,601,233 shares worth $54.8M. The position accounts for 0.82% of the portfolio, ranked #31.

Columbia Wanger Asset Management first reported a position in GHDX in Q3 2016 and has held it in 6 quarters since. 135 funds tracked by Wall St. Rank hold GHDX as of Q4 2017.

Columbia Wanger Asset Management held 1,601,233 shares of Genomic Health, Inc. worth $54.8M as of Q4 2017.
Columbia Wanger Asset Management bought 446,897 Genomic Health, Inc. shares in Q4 2017, an estimated $14.2M.
Genomic Health, Inc. made up 0.82% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #31 holding.
Columbia Wanger Asset Management first reported a position in Genomic Health, Inc. in Q3 2016 and has held it in 6 quarters since.
135 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.